Palmitoyl Tripeptide-5 for Skin Rejuvenation - Quick Reference Sheet
evipedia.ai
← Back

Palmitoyl Tripeptide-5 for Skin Rejuvenation

Created on 09/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Palmitoyl tripeptide-5 is a lab-made cosmetic ingredient in anti-wrinkle creams and serums, built to copy a signal that tells skin cells to make collagen. Human studies tested ingredient mixtures without a peptide-free comparison, and lab work suggests little passes through intact skin, so its own contribution has not been shown. No harm from the peptide itself is reported; it is a low-risk companion to sunscreen and vitamin A creams. (Full Review)

Protocol

Standard formulation
SYN-COLL at 1–2.5% of the formula
Supplier-recommended; products rarely disclose the level, so the delivered dose is usually unknown
Application frequency
Twice daily (morning and evening)
On clean facial skin, typically as a serum under moisturizer and, in the morning, under sunscreen
Best time of day
Evening use
Avoids layering with morning vitamin C or acids; morning use needs sunscreen on top; no study has compared timings
Time to effect
Fewer Wrinkles and Firmer Dermal Structure
12 weeks
Microneedle-patch study with no control group; product studies report changes at 2–12 weeks
Improved Skin Hydration
28 days to 12 weeks
Uncontrolled studies; hydrating carriers mean the peptide's share is unknown
More Even Skin Pigmentation
28 days
Uncontrolled nanoparticle-formula study

Benefits

Contraindications
  • Positive patch test or prior reaction to the product or any of its ingredients
  • Active eczema, rosacea flare, infection or open wounds at the application site
  • Microneedle or post-procedure use with a history of keloids or hypertrophic scars
  • Non-sterile products within 24 hours of ablative (skin-layer-removing) laser treatment or microneedling deeper than 0.5 mm
  • Active skin cancer at the application site (theoretical concern)
  • Pregnancy and breastfeeding (precautionary)
    •
Key Interactions
  • Topical retinoids (tretinoin, tazarotene, adapalene): Monitor
  • Topical corticosteroids (anti-inflammatory steroid creams; hydrocortisone, clobetasol): Caution
  • Oral isotretinoin: Caution with microneedle delivery only
  • Anticoagulants (blood thinners; warfarin, apixaban, rivaroxaban): Caution with microneedle delivery only
  • Over-the-counter exfoliants and oxidizers (glycolic acid, salicylic acid, L-ascorbic acid serums, benzoyl peroxide): Monitor
  • Supplements with additive effects (oral collagen peptides, vitamin C): Additive, no adverse interaction
  • Other topical peptides (copper tripeptide-1, palmitoyl pentapeptide-4, palmitoyl tripeptide-1): Additive
  • Microneedling, lasers and chemical peels: Caution
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Local skin irritation or allergic reaction; granulomas with microneedle delivery; forgone benefit from replacing proven treatments
    •
  • Speculative: Excess scarring or fibrosis; growth of existing skin cancers
    •

Monitoring

Marker Target Why
Standardized facial photography No established target; track change from own baseline Documents wrinkle change
Wrinkle severity grade Lower grade than baseline; no absolute target Validated visual endpoint
Skin elasticity (Cutometer) No established target; track increase from baseline Measures firmness
Skin surface hydration (Corneometer) No established target; track change from baseline Measures moisture
Patch-test result Negative (no redness, itching or swelling) Detects allergy before facial use

Cadence: Baseline photographs, wrinkle grade and 7-day forearm patch test; repeat photographs and grading at 4 weeks, 12 weeks, then every 6 months; daily irritation checks for the first 2 weeks. No change by 12–16 weeks indicates limited response.

Qualitative Assessment

  • Smoothness of skin to the touch
  • Makeup settling less into fine lines
  • Perceived firmness and bounce of skin
  • Tolerance: absence of stinging, redness or itching
  • Overall satisfaction with skin appearance in consistent lighting
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.